Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
BioLargo, Inc. (OTCQX: BLGO) regularly issues news and updates about its cleantech, environmental, energy, and life sciences activities. As a developer of sustainable technologies and a full-service environmental engineering company, its announcements often focus on progress in PFAS water treatment, advanced wastewater solutions, odor and VOC control, air quality, energy storage, and medical infection control and wound care.
Recent news has highlighted BioLargo’s Aqueous Electrostatic Concentrator (AEC) platform, including reported breakthroughs that significantly reduced the system’s energy use in large-scale PFAS treatment and its deployment at a municipal drinking water facility in Lake Stockholm, New Jersey. Coverage also includes recognition of BioLargo Equipment Solutions & Technologies, Inc. in industry media for PFAS treatment advances and updates on commercial demonstration projects.
Investors and observers can also find announcements about BioLargo’s Cellinity battery technology for grid-scale energy storage, its role in broader infrastructure and clean energy discussions, and participation in conferences and investor events such as LD Micro and NobleCon. These items provide context on how the company positions its technologies within evolving infrastructure, data center, and energy investment cycles.
On the life sciences side, news items cover Clyra Medical Technologies’ progress in infection control and advanced wound care, including the ViaCLYR wound irrigation solution and its exclusive distribution alliance with Advanced Solution, LLC. Regulatory, legal, and corporate developments—such as SEC-reported events, financial updates, and intellectual property enforcement actions related to odor control technologies—are also common topics. This news page allows readers to follow BioLargo’s ongoing technical milestones, commercialization steps, and corporate disclosures in one place.
BioLargo, Inc. (OTCQB:BLGO) has announced a municipal wastewater treatment pilot for its innovative water treatment technologies, AOS and AEC, to be conducted near Montréal, Québec. This pilot aims to validate the effectiveness and cost-efficiency of these technologies in treating challenging contaminants in real wastewater environments. Funded partly by a $225,000 CAD grant from NSERC, the project is expected to generate initial results by Q1 2021. BioLargo’s technologies previously demonstrated successful wastewater treatment capabilities at a poultry facility in Alberta.
BioLargo, Inc. (OTCQB:BLGO) released its Q2 2020 highlights, coinciding with its 10-Q filing. The company launched Clyraguard, an FDA-registered disinfectant, achieving strong sales growth. It secured a $1 million inventory line and established distribution partnerships. Upcoming projects include a $500,000 revenue-generating AOS water treatment contract and field pilots for PFAS treatment technology. Despite a 2% revenue decrease in Q2, overall revenue rose 8% for the first half of 2020. BioLargo has converted $3.5 million of debt to equity, strengthening its balance sheet.